SIGN-UP NOW! SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More
top banner

C. diff. Spores and More

Tuesday at 10 AM Pacific

December 18th 2018:Rebiotix: Patients, Clinical Trials and Drug Development

Join us with guests Ken Blount, Ph.D., Chief Scientific Officer and Paul Plumb, Head of Clinical Operations from Rebiotix. Ken and Paul will discuss the gut microbiome and the role it plays in overall health and Rebiotix’s goal to rehabilitate the gut microbiome by utilizing their unique Microbiota Restoration Therapy™ (MRT) Platform through its extensive clinical trial program. The science behind their products, product development and how patients are an important part of helping develop new drugs will also be discussed.

Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Guest Image

Ken F. Blount, Ph.D

Dr. Ken Blount is a seasoned director of research in biotech, pharma, clinical, and academic research settings, and his scientific expertise includes antibiotics discovery and development, fecal microbiome analysis, translational medical oncology, and RNA-targeting therapeutics. Prior to joining Rebiotix, Dr. Blount coordinated translational urologic oncology research for the Yale Cancer Center. He was a cofounder and Director of Biology at BioRelix, a biotech that developed new antibiotics to target structured bacterial messenger RNAs. At BioRelix, he led a force of internal scientists and external resources that delivered development candidates for treating Clostridium difficile infecti
Read more
Guest Image

Paul Plumb

Paul Plumb joined the Rebiotix clinical team in 2015, and currently serves as the Head of Clinical Operations. He has over 30 years of medical technology and healthcare delivery experience, focused on minimally-invasive techniques, investigational devices, and most recently new drug development in the microbiome field. Prior to Rebiotix, Paul held leadership roles in clinical research, brand and marketing management at organizations including Zimmer Biomet, VertiFlex, and Allina Healthcare
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 17/06/2019 08:00 17/06/2019 09:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Join us with guests Ken Blount, Ph.D., Chief Scientific Officer and Paul Plumb, Head of Clinical Operations from Rebiotix. Ken and Paul will discuss the gut microbiome and the role it plays in overall health and Rebiotix’s goal to rehabilitate the gut microbiome by utilizing their unique Microbiota Restoration Therapy™ (MRT) Platform through its extensive clinical trial program. The science behind their products, product development and how patients are an important part of helping develop new drugs will also be discussed. VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY Add to Calendar
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
Facebook Twitter Linkedin Social Media
presspass-banner